Abstract |
Previously, we found that orally administered soymetide-4 (MITL), an immunostimulating peptide derived from soybean beta-conglycinin alpha' subunit, suppressed alopecia induced by the anti- cancer drug etoposide in neonatal rats. Soymetide-4 has weak affinity for N-formyl-methionyl-leucyl-phenylalanine ( fMLP) receptor. fMLP showed an anti- alopecia effect after intraperitoneal administration, though it was inactive after oral administration. Anti- alopecia effect of fMLP was blocked by pyrilamine or cimetidine, antagonists for histamine H1 or H2 receptor, respectively. However, the anti- alopecia effect of soymetide-4 was not inhibited by the histamine antagonists but by indomethacin, an inhibitor of cyclooxygenase (COX), or AH-23848B, an antagonist of the EP4 receptor for PGE2. Anti- alopecia effect of soymetide-4 was also blocked by pyrrolidine dithiocarbamate, an inhibitor of nuclear factor-kappaB ( NF-kappaB). These results suggest that PGE2, which is produced after activation of COX by soymetide-4, might suppress apoptosis of hair matrix cells and etoposide-induced alopecia by activating NF-kappaB.
|
Authors | Takahiro Tsuruki, Kyoya Takahata, Masaaki Yoshikawa |
Journal | Peptides
(Peptides)
Vol. 26
Issue 5
Pg. 707-11
(May 2005)
ISSN: 0196-9781 [Print] United States |
PMID | 15808899
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Antigens, Plant
- Antineoplastic Agents, Phytogenic
- Biphenyl Compounds
- Cyclooxygenase Inhibitors
- Globulins
- Histamine H1 Antagonists
- NF-kappa B
- Peptide Fragments
- Pyrrolidines
- Receptors, Formyl Peptide
- Receptors, Prostaglandin E
- Receptors, Prostaglandin E, EP4 Subtype
- Seed Storage Proteins
- Soybean Proteins
- Thiocarbamates
- beta-conglycinin protein, Glycine max
- soymetide-4
- pyrrolidine dithiocarbamic acid
- N-Formylmethionine Leucyl-Phenylalanine
- Etoposide
- AH 23848
- Prostaglandin-Endoperoxide Synthases
- Indomethacin
|
Topics |
- Adjuvants, Immunologic
(pharmacology, therapeutic use)
- Administration, Oral
- Alopecia
(prevention & control)
- Animals
- Antigens, Plant
- Antineoplastic Agents, Phytogenic
(toxicity)
- Biphenyl Compounds
(pharmacology)
- Cyclooxygenase Inhibitors
(pharmacology)
- Etoposide
(toxicity)
- Female
- Globulins
(chemistry)
- Histamine H1 Antagonists
(pharmacology)
- Indomethacin
(pharmacology)
- Male
- N-Formylmethionine Leucyl-Phenylalanine
(pharmacology)
- NF-kappa B
(antagonists & inhibitors)
- Peptide Fragments
(administration & dosage, pharmacology, therapeutic use)
- Prostaglandin-Endoperoxide Synthases
(drug effects, metabolism)
- Pyrrolidines
(pharmacology)
- Rats
- Receptors, Formyl Peptide
(drug effects)
- Receptors, Prostaglandin E
(antagonists & inhibitors, metabolism)
- Receptors, Prostaglandin E, EP4 Subtype
- Seed Storage Proteins
- Soybean Proteins
(administration & dosage, chemistry, pharmacology, therapeutic use)
- Thiocarbamates
(pharmacology)
|